News from CTI, AndersonBrecon and CIS – People on the move
Outsourcing-Pharma.com presents its weekly round-up of the latest career climbers including news from CTI, AndersonBrecon and CIS.
Archives for November 22, 2012
Update - comments from EFPIA
EC asks pharmas how long to add 'black symbol' to risky drugs
The European Commission (EC) has asked the industry how long it will take to change labels of drugs marked for additional post-market monitoring.
Johnson Matthey's API biz on the up whilst catalyst profits dip
Johnson Matthey saw an uptick in its API business thanks to demand for “higher margin” products.
SAFC to be renamed under Sigma-Aldrich business rejig
Sigma-Aldrich has announced a plan to realign its business operations along regional and customer-focused lines.
News from CPhI
Single-use lets some Pharmas make own potent drugs but outsourcing demand still strong: Alkermes
Single-use technology will see more HP production brought in-house but contract manufacturers will still win-out, according to Alkermes.
FDA stresses importance of IRB role in new draft guidelines
The US FDA wants IRBs to remember it is their responsibility to check investigator qualifications, make sure sites are up to code and say if an IND is necessary for the proposed trial.